American Financial Group’s Onconetix ONCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8
Closed -$2.81K 63
2025
Q1
$2.81K Hold
8
﹤0.01% 61
2024
Q4
$22.7K Hold
8
0.01% 62
2024
Q3
$187K Hold
8
0.08% 61
2024
Q2
$241K Hold
8
0.1% 61
2024
Q1
$222K Hold
8
0.08% 64
2023
Q4
$285K Hold
8
0.1% 66
2023
Q3
$737K Hold
8
0.25% 60
2023
Q2
$1.63M Buy
8
+2
+33% +$348K 0.5% 43
2023
Q1
$1.01M Hold
6
0.31% 50
2022
Q4
$1.03M Buy
6
+3
+100% +$641K 0.35% 52
2022
Q3
$781K Buy
3
+1
+50% +$438K 0.27% 54
2022
Q2
$858K Hold
2
0.29% 53
2022
Q1
$22.8M Buy
+2
New +$18.3M 6.92% 3

Other funds holding ONCO

American Financial Group's ONCO Position: Q2 2025 in Review

American Financial Group sold out of Onconetix (ONCO) in Q2 2025, closing a stake of 8 shares — an estimated $2.81K sold.

American Financial Group first reported a position in ONCO in Q1 2022 and held it in 13 quarters. The position peaked at $22.8M in Q1 2022. 5 funds tracked by Wall St. Rank hold ONCO as of Q2 2025.

  • American Financial Group reported no remaining Onconetix position as of Q2 2025 after selling out during the quarter.
  • American Financial Group sold 8 Onconetix shares in Q2 2025, an estimated $2.81K.
  • American Financial Group first reported a position in Onconetix in Q1 2022 and held it in 13 quarters.
  • American Financial Group's Onconetix position peaked at $22.8M in Q1 2022.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q2 2025.

Based on American Financial Group's 13F filing for Q2 2025, filed 7 Aug 2025.